Land This Bargain Even Cheaper Than CEO Simon, Did
October 14, 2016 at 10:00 AM EDT
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on August 4, Haemonetics Corp.'s CEO, Christopher Simon,, invested $2,099,754.00 into 60,000 shares of HAE, for a cost per share of $35.00..
